Lonza/ CH0013841017 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -SGD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 58.34 bill.SGD | - | - |
GlobeNewswire
05-15
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire
05-08
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
04-04
Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire
04-04
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire
02-27
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
01-04
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire
2023-12-19
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire
2023-12-09
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
2023-12-07
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire
2023-11-06
Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-10-16
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire
2023-10-02
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire
2023-09-20
Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
GlobeNewswire
2023-09-07
Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire
2022-03-14
aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
